COVID-19 pandemic lockdown international impact on nAMD, DME and RVO intravitreal therapy outcomes: Fight Retinal Blindness International registry
Javier Zarranz-Ventura, Vuong Nguyen, Catherine Creuzot-Garcher, Frank D. Verbraak, Louise O'Toole, Alessandro Invernizzi, Francesco Viola, David Squirrell, Daniel Barthelmes, Mark C. Gillies
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.